首页>
外国专利>
MEDICINAL AGENT FOR TREATMENT OF ATYPICAL PNEUMONIA
MEDICINAL AGENT FOR TREATMENT OF ATYPICAL PNEUMONIA
展开▼
机译：治疗非典型肺炎的药物
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine, virology, pharmacy.;SUBSTANCE: invention proposes an agent for treatment and prophylaxis of infection caused by coronaviruses, in particular, for treatment of atypical pneumonia (SARS), and pharmaceutical composition of indicated designation based on thereof. Agent represents 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-oxybromoindole or 1-methyl-2-phenylthiomethyl-3-carbethoxy-4-dimethylaminomethyl-5-oxybromoindole monohydrate hydrochloride (arbidol) known early as an immunomodulator and preparation used against influenza viruses. Invention provides reducing accumulation of coronaviruses (on example with TOPS virus) in lung.;EFFECT: valuable medicinal properties of agent.;2 cl, 7 tbl, 9 ex
展开▼
机译：发明领域本发明提出了一种用于治疗和预防由冠状病毒引起的感染的试剂，特别是用于治疗非典型肺炎（SARS）的药物，以及基于该试剂的指定药物组合物。药剂代表1-甲基-2-苯基硫甲基-3-碳乙氧基-4-二甲氨基甲基-5-氧基溴吲哚或1-甲基-2-苯基硫甲基-3-碳乙氧基-4-二甲基氨基甲基-5-氧基溴吲哚一水合物盐酸盐（arbidol），早期称为用于流感病毒的免疫调节剂和制剂。本发明减少了冠状病毒（例如TOPS病毒）在肺中的积累。效果：该药剂的有价值的医学特性; 2 cl，7 tbl，9 ex
展开▼
